129 related articles for article (PubMed ID: 2699488)
1. Comparison of therapeutic efficacy of continuous ambulatory peritoneal dialysis between diabetic and non-diabetic patients: three years of experience.
Tsai TJ; Tsai HF; Wu MS; Chuang CM; Chen WY
Taiwan Yi Xue Hui Za Zhi; 1989 Oct; 88(10):1000-7. PubMed ID: 2699488
[TBL] [Abstract][Full Text] [Related]
2. [Continuous ambulatory peritoneal dialysis treatment and blood glucose control in diabetics with end-stage diabetic nephropathy].
Li GW; Liu J; Chen L
Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):360-3, 382. PubMed ID: 2684575
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction in uremic patients on continuous ambulatory peritoneal dialysis (CAPD).
Rašić S; Hadžović-Džuvo A; Rebić D; Valjevac A; Unčanin S
Bosn J Basic Med Sci; 2011 Aug; 11(3):153-7. PubMed ID: 21875416
[TBL] [Abstract][Full Text] [Related]
4. [Continuous ambulatory peritoneal dialysis in diabetic patients].
Stojimrović B; Nesić V
Srp Arh Celok Lek; 1998; 126(7-8):277-82. PubMed ID: 9863395
[TBL] [Abstract][Full Text] [Related]
5. Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy.
Chen HC; Lai YH; Tsai CY; Shin SJ; Tsai JH
Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):56-61. PubMed ID: 2005672
[TBL] [Abstract][Full Text] [Related]
6. Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on continuous ambulatory peritoneal dialysis.
Yu CC; Wu MS; Wu CH; Yang CW; Huang JY; Hong JJ; Fan Chiang CY; Leu ML; Huang CC
Perit Dial Int; 1997; 17(3):262-8. PubMed ID: 9237287
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
Babazono T; Miyamae M; Tomonaga O; Omori Y
Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
[TBL] [Abstract][Full Text] [Related]
8. Long-term continuous ambulatory peritoneal dialysis in diabetics.
Balaskas EV; Yuan ZY; Gupta A; Meema HE; Blair G; Bargman J; Oreopoulos DG
Clin Nephrol; 1994 Jul; 42(1):54-62. PubMed ID: 7923968
[TBL] [Abstract][Full Text] [Related]
9. CAPD and transplantation in diabetics.
Passlick J; Grabensee B
Clin Nephrol; 1988; 30 Suppl 1():S18-23. PubMed ID: 3052957
[TBL] [Abstract][Full Text] [Related]
10. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): an in vivo model for the study of diabetic microangiopathy.
Di Paolo N; Sacchi G
Perit Dial Int; 1989; 9(1):41-5. PubMed ID: 2488179
[TBL] [Abstract][Full Text] [Related]
12. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
Ersoy FF; Karayalcin U; Karayalcin B; Sapan M; Bozcuk H; Süleymanlar G; Yakupoglu G
Adv Perit Dial; 1995; 11():119-22. PubMed ID: 8534683
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.
Grzegorzewska AE; Mariak I
Adv Perit Dial; 2001; 17():5-9. PubMed ID: 11510296
[TBL] [Abstract][Full Text] [Related]
14. Continuous ambulatory peritoneal dialysis (CAPD) in patients with diabetic nephropathy.
Kemperman FA; van Leusen R; van Liebergen FJ; Oosting J; Boeschoten EW; Struijk DG; Krediet RT; Arisz L
Neth J Med; 1991 Jun; 38(5-6):236-45. PubMed ID: 1922596
[TBL] [Abstract][Full Text] [Related]
15. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
Scarpioni L; Ballocchi S; Castelli A; Scarpioni R
Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664
[TBL] [Abstract][Full Text] [Related]
16. Continuous ambulatory peritoneal dialysis in type II diabetics.
Wei SS; Lee GS; Woo KT; Lim CH
Ann Acad Med Singap; 1993 Jul; 22(4):629-33. PubMed ID: 8257073
[TBL] [Abstract][Full Text] [Related]
17. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
[TBL] [Abstract][Full Text] [Related]
18. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
Serlie MJ; Struijk DG; de Blok K; Krediet RT
Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
[TBL] [Abstract][Full Text] [Related]
19. CAPD in diabetics: use of aminoacids.
Renzo S; Beatrice D; Giuseppe I
Adv Perit Dial; 1990; 6():53-5. PubMed ID: 1982840
[TBL] [Abstract][Full Text] [Related]
20. Xylitol as osmotic agent in CAPD: an alternative to glucose for uremic diabetic patients?
Bazzato G; Coli U; Landini S; Fracasso A; Morachiello P; Righetto F; Scanferla F; Onesti G
Trans Am Soc Artif Intern Organs; 1982; 28():280-6. PubMed ID: 6761936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
